Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.

S'inscrire

MAPP

Harbor ETF Trust (MAPP)

Harbor ETF Trust Multi-Asset Explorer

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NYSE:MAPP

Date	Heure	Source	Titre	Symbole	Société
16/02/2010	13h00	PR Newswire (US)	MAP Pharmaceuticals Announces Initiation of LEVADEX(TM) Pharmacokinetics Trial	NYSE:MAPP
06/01/2010	13h00	PR Newswire (US)	MAP Pharmaceuticals to Present at the 28th Annual J.P. Morgan Healthcare Conference	NYSE:MAPP
12/11/2009	13h00	PR Newswire (US)	MAP Pharmaceuticals Secures $60 Million Committed Equity Financing Facility	NYSE:MAPP
11/11/2009	13h00	PR Newswire (US)	MAP Pharmaceuticals to Present at the Lazard Capital Markets 6th Annual Healthcare Conference	NYSE:MAPP
29/10/2009	12h00	PR Newswire (US)	MAP Pharmaceuticals Completes Interim Safety Review of LEVADEX(TM) Open-Label Safety Extension in More Than 400 Patients	NYSE:MAPP
10/09/2009	13h00	PR Newswire (US)	MAP Pharmaceuticals' Analysis of Positive Phase 3 LEVADEX(TM) Data To Be Presented in Late-Breaking Session at 14th Congress of	NYSE:MAPP
02/09/2009	13h00	PR Newswire (US)	MAP Pharmaceuticals to Present at Upcoming Healthcare and Scientific Conferences	NYSE:MAPP
09/07/2009	15h40	Dow Jones News	AstraZeneca Terminates MAP Pharma Pact, Sees $44 Million charge In 2Q	NYSE:MAPP	MAP Pharmaceuticals Inc.
09/07/2009	14h30	PR Newswire (US)	MAP Pharmaceuticals Announces Termination of Pediatric Asthma Collaboration	NYSE:MAPP
05/10/2007	15h00	PR Newswire (US)	MAP Pharmaceuticals Announces Pricing of Its Initial Public Offering	NYSE:MAPP